Mounjaro (tirzepatide) is a prescription medication developed by Eli Lilly, primarily used to improve blood sugar control in adults with type 2 diabetes. It is also being studied and increasingly used for weight management in people with or without diabetes due to its significant effects on appetite and metabolism.